Villabeto, Roxan D.
HRN: 04-16-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFUROXIME 1.5GM (VIAL)
05/06/2022
05/06/2022
IV
1.5g
Once
For Repeat CS
Waiting Final Action
05/08/2022
CEFUROXIME 500MG (TAB)
05/08/2022
05/14/2022
PO
500mg
BID
S/P LP CS
Waiting Final Action